ARPA-H’s new FRONT program funds regenerative brain tissue therapies to reverse “permanent” damage from stroke and trauma.
Archives
ARPA-H’s new FRONT program funds regenerative brain tissue therapies to reverse “permanent” damage from stroke and trauma.